Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0001601830-24-000166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-03 | 2024-10-01 | RXRX | Borgeson Blake | Dir | S - Sale | $6.22 | -11.4K | 7.10M | -0.2% | -$71.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-10-01 | S | D | 11,447 | $6.22 | 7,098,428 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $6.09 to $6.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |